How many institutions held DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value in Q1 2025?

47 institutional investors reported DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value for Q1 2025. Use the holders table for investor-level position and value details.

PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value (DTIL)

Q: What does CUSIP 74019P207 represent in this 13F holders report?

CUSIP 74019P207 is the security identifier for DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value used to aggregate holder disclosures.

CUSIP: 74019P207

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class: Equity / Common Stock, $0.000005 par value
Total 13F shares: 3,786,321
Total 13F value: $18,062,451
Share change: -72,925
SEC-reported price per share: $4.77
Number of holders: 47
Value change: +$340,769
Number of buys: 15
Number of sells: 21
Shares outstanding: 28,821,937

Security key

74019P207

Report period

Q1 2025

Institutions

Top holders

DTIL full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 PRECISION BIOSCIENCES INC SEC filings PRECISION BIOSCIENCES INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 74019P207

Newer quarter: Q3 2025

Recent filing periods:

Q3 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

HIGHBRIDGE CAPITAL MANAGE...

Disclosed value leader

NOVARTIS PHARMA AG

Comparable rows

1/15

Latest evidence

31 Mar 2025

13D/G 3/4/5 13F Lead comparable stake: 3.7% 14 rows are not safely comparable across share classes. 13D/G row: HIGHBRIDGE CAPITAL MANAGEMENT LLC Showing 1-6 of 15 holder rows.

Quick read

HIGHBRIDGE CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 3.7%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HIGHBRIDGE CAPITAL MANAGEMENT LLC's linked filing trail.

Comparable ownership Top 1

HIGHBRIDGE CAPITAL MANAGEMENT LLC 3.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13D/G 13D/G	3.7% Reported 13D/G · 31 Mar 2025	$2,165,312 406,250 shares	$0	31 Mar 2025
NOVARTIS PHARMA AG	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$4,590,753 12,407,440 shares	—	15 Jun 2022
Lynx1 Capital Management LP	13F Company 13F	— denominator unverified	$2,918,654 766,051 shares	—	31 Dec 2024
TANG CAPITAL MANAGEMENT LLC	13F Company 13F	— denominator unverified	$2,565,395 673,332 shares	—	31 Dec 2024
Aquilo Capital Management, LLC	13F Company 13F	— denominator unverified	$2,043,593 536,376 shares	—	31 Dec 2024
Derek Jantz	3/4/5 Chief Scientific Officer, Director 3/4/5	— mixed-class rows	$1,509,439 4,079,565 shares mixed-class rows	—	07 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,786,321

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2025 holders

Holder diff

-20

Investor	Q4 2025 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q4 2025 value	Q1 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend